- Conditions: cUTI; Complicated Urinary Tract Infection; Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Conditions: Histologically Confirmed Medulloblastoma; Activation of the Sonic Hedgehog (SHH) Pathway
Interventions: Drug: vismodegib; Drug: Temozolomide
Sponsors: Centre Leon Berard; Centre Leon Berard; Ministry of Health, France
Not yet recruiting - verified May 2012 - Conditions: Urinary Incontinence; Multiple Sclerosis
Interventions: Biological: OnabotulinumtoxinA; Drug: Placebo (Normal Saline); OnabotulinumtoxinA
Sponsors: Allergan; Allergan
Not yet recruiting - verified May 2012 - Condition: Pulmonary Arterial Hypertension
Intervention:
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified September 2011 - Conditions: Type 2 Diabetes Mellitus; Overweight
Intervention: Drug: Liraglutide
Sponsors: Centre Hospitalier Universitaire Dijon; Centre Hospitalier Universitaire Dijon
Completed - verified April 2012 - Condition: Elderly Patients
Interventions: Dietary Supplement: Citrulline; Dietary Supplement: Non essential amino acid
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified April 2012 - Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel, 0.015%; Drug: Vehicle gel
Sponsors: LEO Pharma; LEO Pharma
Recruiting - verified May 2012 - Relation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell CarcinomaCondition: Renal Cell Carcinoma
Intervention: Other: Blood sample
Sponsors: Centre Francois Baclesse; Centre Francois Baclesse; University Hospital, Caen
Recruiting - verified May 2012 - Conditions: Oral Therapies; Cancer; Cognitive Function; Compliance
Intervention:
Sponsors: Centre Francois Baclesse; Centre Francois Baclesse
Recruiting - verified February 2012 - Condition: Kidney Failure
Interventions: Drug: cyclosporin + mycophenolate mofetil; Drug: everolimus + mycophenolate mofetil
Sponsors: Centre Hospitalier Universitaire, Amiens; Centre Hospitalier Universitaire, Amiens; Novartis
Recruiting - verified May 2012 - Condition: Ovarian Endometrioma
Interventions: Procedure: Ablation using the PlasmaJet system; Procedure: Cystectomy
Sponsors: Plasma Surgical Inc; Plasma Surgical Inc
Recruiting - verified May 2012 - Condition: Ischemic Heart Disease
Intervention: Drug: adenosine + dipyridamole
Sponsors: Adenobio N.V; Adenobio N.V
Recruiting - verified May 2012 - Condition: Efficacy and Tolerance of B-Back® on the Burnout Syndrome
Interventions: Dietary Supplement: Dietary supplement : B-Back® (α-casozepine, taurine, eleutherococcus senticosus, Extramel); Dietary Supplement: B-Back® placebo (without active compounds)
Sponsors: Université Victor Segalen Bordeaux 2; Université Victor Segalen Bordeaux 2; Nanox International Laboratory (Belgique)
Recruiting - verified May 2012 - Condition: Pain
Interventions: Device: Epidural catheter placement; Procedure: Epidural catheter placement
Sponsors: Hopital Foch; Hopital Foch
Not yet recruiting - verified May 2012 - Condition: Anesthesia
Interventions: Drug: Gelatin 500 mL; Drug: Gelatin 50 mL
Sponsors: Hopital Foch; Hopital Foch
Not yet recruiting - verified May 2012 - Condition: Metastatic Colorectal Cancer
Intervention: Other: Blood analysis by EPISPOT and Cellsearch
Sponsors: University Hospital, Montpellier; University Hospital, Montpellier; National Cancer Institute, France; Direction Générale de l'Offre de Soins; Roche Pharma AG
Recruiting - verified May 2012 - Condition: Peripheral Artery Disease
Intervention: Device: electrical muscle stimulation
Sponsors: University Hospital, Angers; University Hospital, Angers
Recruiting - verified May 2012 - Conditions: ICD; Sudden Cardiac Death; Ventricular Fibrillation; Atrial Fibrillation; Ventricular Tachycardia
Intervention:
Sponsors: Biotronik SE & Co. KG; Biotronik SE & Co. KG
Recruiting - verified May 2012 - Condition: Branch Retinal Vein Occlusion
Interventions: Drug: Ranibizumab; Procedure: Laser
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Intestinal Bacteria Flora Disturbance
Intervention:
Sponsors: Da Volterra; Da Volterra
Recruiting - verified May 2012 - Anxiety and Depression in Relatives of Critically Ill Patients: Spouses Versus Other Close RelativesConditions: Stress Disorders, Post-Traumatic; Anxiety; Depression
Intervention:
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified April 2012 - Condition: Non Shockable Out of Hospital Cardiac Arrest
Interventions: Drug: Cyclosporine A; Procedure: cardio-pulmonary resuscitation
Sponsors: Hospices Civils de Lyon; Hospices Civils de Lyon
Recruiting - verified May 2012 - Conditions: Shock; Circulatory Failure
Intervention:
Sponsors: Centre Hospitalier Universitaire de Nīmes; Centre Hospitalier Universitaire de Nīmes
Not yet recruiting - verified April 2012 - Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital PalliativeCondition: Cancer
Intervention: Behavioral: interview with a doctor for evaluating suicide risk
Sponsors: Centre Francois Baclesse; Centre Francois Baclesse
Recruiting - verified April 2012 - Conditions: Anterior Cruciate Ligament Reconstruction; Subchondral Microfractures of Tibia
Intervention:
Sponsors: Hôpital Ambroise Paré; Hôpital Ambroise Paré
Recruiting - verified April 2012 - Condition: Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
Intervention: Drug: LCQ908
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified April 2012 - Conditions: Fetal Growth Retardation; High-Risk Pregnancy
Interventions: Other: ultrasound examination; Other: ultrasound examination
Sponsors: University Hospital, Rouen; University Hospital, Rouen
Not yet recruiting - verified May 2012 - Condition: Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem; Drug: Either 500 mg of Ciprofloxacin (oral); Drug: or 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Condition: Osteoporosis
Intervention:
Sponsors: Central Hospital, Nancy, France; Central Hospital, Nancy, France
Recruiting - verified April 2012 - Condition: Mild to Moderate Psoriasis
Interventions: Other: TTOP; Other: non-TTOP
Sponsors: Reich, Kristian, M.D.; Kristian Reich, MD; LEO Pharma
Recruiting - verified May 2012 - Condition: Goiter, Nodular
Intervention: Procedure: Galectin 3 dosage
Sponsors: University Hospital, Rouen; University Hospital, Rouen
Not yet recruiting - verified April 2012 - Conditions: Diabetes Mellitus; Diabetic Neuropathic Foot Ulcer
Interventions: Device: SANIDIAB; Device: BAROUK
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; MAYZAUD
Recruiting - verified April 2012 - Conditions: No Placental Abruption; No Hemorrhage
Intervention: Device: Suction cup Hemostatic Intra-Uterine, device not marked CE (not marketed)
Sponsors: University Hospital, Grenoble; AdministrateurCIC
Not yet recruiting - verified April 2012 - Condition: Acute Respiratory Distress Syndrome
Interventions: Other: Recruitment Maneuver (RM) sham group; Other: Sham recruitment maneuver (RM) group
Sponsors: University Hospital, Clermont-Ferrand; University Hospital, Clermont-Ferrand
Recruiting - verified May 2012 - Condition: Cow's Milk Allergy
Intervention: Other: Amino Acid formula
Sponsors: Mead Johnson Nutrition; Mead Johnson Nutrition
Recruiting - verified April 2012 - Conditions: Follicular Lymphoma Patients (Phase IB); Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
Intervention: Drug: Lenalidomide and GA101
Sponsors: Groupe d'Etude des Lymphomes de l'Adulte - Recherche Clinique; Groupe d'Etude des Lymphomes de l'Adulte - Recherche Clinique
Not yet recruiting - verified April 2012 - Condition: Healthy Adults
Interventions: Other: 1-Increased water intake regimen; Other: 2-Non-modified water intake regimen
Sponsors: Danone Research; Danone Research; Centre CAP
Completed - verified April 2012 - Conditions: Dementia; Alzheimer Disease
Intervention: Other: Neuroimaging
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux
Not yet recruiting - verified April 2012 - Conditions: Amyotrophic Lateral Sclerosis; Respiratory Insufficiency
Interventions: Device: phenique nerve stimulation NeurX™ (Synapse Biomedical); Device: sham phrenic nerve stimulation
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; ARSla (Association pour la recherche sur la SLA); Fondation Thierry Latran
Not yet recruiting - verified April 2012 - Conditions: Acute Respiratory Failure; Critical Illness; Ventilation Weaning
Interventions: Other: VARIABLE-PSV ventilatory mode; Other: STANDARD-PSV ventilatory mode
Sponsors: University Hospital, Montpellier; University Hospital, Montpellier
Not yet recruiting - verified April 2012 - Conditions: Diabetic Nephropathy; Persistent Proteinuria With Type II Diabetes
Interventions: Procedure: Percutaneous renal denervation and TMNS; Drug: Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified March 2012 - Condition: Surgery
Intervention: Device: Pain Monitor
Sponsors: Hopital Foch; Hopital Foch
Recruiting - verified May 2012 - Condition: Anesthesia
Interventions: Drug: Propofol (Astra-Zeneca), NaCl 0.9%; Drug: propofol 1% (Astra-Zeneca) and remifentanil; Drug: propofol 1% (Astra-Zeneca) and remifentanil; Drug: Propofol (Astra-Zeneca), NaCl 0.9%; Drug: Propofol (Astra-Zeneca) and remifentanil; Drug: Propofol (Astra-Zeneca) and remifentanil; Drug: Propofol (B-Braun) and NaCl 0.9%; Drug: Propofol (B-Braun) and remifentanil; Drug: Propofol (B-Braun) and remifentanil
Sponsors: Hopital Foch; Hopital Foch
Recruiting - verified May 2012
 |
Find Paid Clinical Trials in France |
Clinical Trial Locations 